In this episode of the Arbitration Conversation, Amy interviews Allen Waxman, the President & CEO of the International Institute for Conflict Prevention and Resolution (CPR).
Prior to joining CPR, Mr. Waxman served as General Counsel of Pfizer, at Eisai Inc – the North American affiliate of the Japanese-based pharmaceutical company, Eisai Co Ltd – where he also led the Market Access business unit, and at Roivant Sciences, a start-up building biotech and healthcare technology companies. He also practiced law as a partner at Williams & Connolly, in Washington, D.C.
In this round of Arbitration Tips-N-Tools, Professor Amy Schmitz asks some of the leading arbitration practitioners about the biggest pitfalls of consumer arbitration in its current state, especially in a...By Steven Shapiro, Imre Szalai, Erin Archerd, Amy Schmitz
This article was first published on the Securities Arbitration Alert blog, here. Oppenheimer has moved to vacate a massive Award rendered against it by a FINRA Panel. We reported in...By George Friedman
The 2021 Delos Rules of Arbitration came into effect on 1 November 2021, the first major revision since the institution was established in 2014. The updated rules introduce a number of innovations aimed at...By Marco de Sousa